{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T23:25:50Z","timestamp":1768778750388,"version":"3.49.0"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2023,7,23]],"date-time":"2023-07-23T00:00:00Z","timestamp":1690070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,7,23]],"date-time":"2023-07-23T00:00:00Z","timestamp":1690070400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["16K18793"],"award-info":[{"award-number":["16K18793"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["148781"],"award-info":[{"award-number":["148781"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Ohyama Health Foundation, Inc."},{"DOI":"10.13039\/501100013236","name":"MSD Life Science Foundation, Public Interest Incorporated Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013236","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Divers"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1007\/s11030-023-10704-9","type":"journal-article","created":{"date-parts":[[2023,7,23]],"date-time":"2023-07-23T02:01:26Z","timestamp":1690077686000},"page":"2667-2680","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["In vitro trypanocidal activities and structure\u2013activity relationships of ciprofloxacin analogs"],"prefix":"10.1007","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5181-9428","authenticated-orcid":false,"given":"Helena D.","family":"Janse van Rensburg","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5809-8811","authenticated-orcid":false,"given":"Keisuke","family":"Suganuma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2327-0551","authenticated-orcid":false,"given":"David D.","family":"N\u2019Da","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,7,23]]},"reference":[{"issue":"2","key":"10704_CR1","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1002\/ddr.21664","volume":"83","author":"F Altamura","year":"2022","unstructured":"Altamura F, Rajesh R, Catta-Preta CM, Moretti NS, Cestari I (2022) The current drug discovery landscape for trypanosomiasis and leishmaniasis: challenges and strategies to identify drug targets. Drug Dev Res 83(2):225\u2013252. https:\/\/doi.org\/10.1002\/ddr.21664","journal-title":"Drug Dev Res"},{"issue":"9709","key":"10704_CR2","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/S0140-6736(09)60829-1","volume":"375","author":"R Brun","year":"2010","unstructured":"Brun R, Blum J, Chappuis F, Burri C (2010) Human African trypanosomiasis. Lancet 375(9709):148\u2013159. https:\/\/doi.org\/10.1016\/S0140-6736(09)60829-1","journal-title":"Lancet"},{"issue":"10110","key":"10704_CR3","doi-asserted-by":"publisher","first-page":"2397","DOI":"10.1016\/S0140-6736(17)31510-6","volume":"390","author":"P B\u00fcscher","year":"2017","unstructured":"B\u00fcscher P, Cecchi G, Jamonneau V, Priotto G (2017) Human African trypanosomiasis. Lancet 390(10110):2397\u20132409. https:\/\/doi.org\/10.1016\/S0140-6736(17)31510-6","journal-title":"Lancet"},{"issue":"1","key":"10704_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13071-019-3355-5","volume":"12","author":"M Cayla","year":"2019","unstructured":"Cayla M, Rojas F, Silvester E, Venter F, Matthews KR (2019) African trypanosomes. Parasit Vectors 12(1):1\u20138. https:\/\/doi.org\/10.1186\/s13071-019-3355-5","journal-title":"Parasit Vectors"},{"issue":"1","key":"10704_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13071-022-05190-1","volume":"15","author":"M Desquesnes","year":"2022","unstructured":"Desquesnes M, Gonzatti M, Sazmand A, Th\u00e9venon S, Bossard G, Boulang\u00e9 A, Gimonneau G, Truc P, Herder S, Ravel S (2022) A review on the diagnosis of animal trypanosomoses. Parasit Vectors 15(1):1\u201324. https:\/\/doi.org\/10.1186\/s13071-022-05190-1","journal-title":"Parasit Vectors"},{"issue":"14","key":"10704_CR6","doi-asserted-by":"publisher","first-page":"1862","DOI":"10.1017\/S0031182016001268","volume":"143","author":"F Giordani","year":"2016","unstructured":"Giordani F, Morrison LJ, Rowan TG, De Koning HP, Barrett MP (2016) The animal trypanosomiases and their chemotherapy: a review. Parasitology 143(14):1862\u20131889. https:\/\/doi.org\/10.1017\/S0031182016001268","journal-title":"Parasitology"},{"issue":"7","key":"10704_CR7","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.3390\/microorganisms10071298","volume":"10","author":"A Venturelli","year":"2022","unstructured":"Venturelli A, Tagliazucchi L, Lima C, Venuti F, Malpezzi G, Magoulas GE, Santarem N, Calogeropoulou T, Cordeiro-da-Silva A, Costi MP (2022) Current treatments to control African trypanosomiasis and one health perspective. Microorganisms 10(7):1298. https:\/\/doi.org\/10.3390\/microorganisms10071298","journal-title":"Microorganisms"},{"issue":"1","key":"10704_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1476-072X-9-57","volume":"9","author":"PP Simarro","year":"2010","unstructured":"Simarro PP, Cecchi G, Paone M, Franco JR, Diarra A, Ruiz JA, F\u00e8vre EM, Courtin F, Mattioli RC, Jannin JG (2010) The atlas of human African trypanosomiasis: a contribution to global mapping of neglected tropical diseases. Int J Health Geogr 9(1):1\u201318. https:\/\/doi.org\/10.1186\/1476-072X-9-57","journal-title":"Int J Health Geogr"},{"issue":"1","key":"10704_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1756-3305-5-109","volume":"5","author":"L Peacock","year":"2012","unstructured":"Peacock L, Cook S, Ferris V, Bailey M, Gibson W (2012) The life cycle of Trypanosoma (nannomonas) congolense in the tsetse fly. Parasit Vectors 5(1):1\u201313. https:\/\/doi.org\/10.1186\/1756-3305-5-109","journal-title":"Parasit Vectors"},{"key":"10704_CR10","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/194176","author":"M Desquesnes","year":"2013","unstructured":"Desquesnes M, Holzmuller P, Lai DH, Dargantes A, Lun ZR, Jittaplapong S (2013) Trypanosoma evansi and surra: a review and perspectives on origin, history, distribution, taxonomy, morphology, hosts, and pathogenic effects. Biomed Res Int. https:\/\/doi.org\/10.1155\/2013\/194176","journal-title":"Biomed Res Int"},{"key":"10704_CR11","unstructured":"WHO. Trypanosomiasis, human African (sleeping sickness). https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/trypanosomiasis-human-african-(sleeping-sickness). Accessed on 23 Nov 2022"},{"key":"10704_CR12","doi-asserted-by":"publisher","DOI":"10.3389\/fvets.2022.828111","author":"KI Kasozi","year":"2022","unstructured":"Kasozi KI, MacLeod ET, Ntulume I, Welburn SC (2022) An update on African trypanocide pharmaceutics and resistance. Front Vet Sci. https:\/\/doi.org\/10.3389\/fvets.2022.828111","journal-title":"Front Vet Sci"},{"issue":"2","key":"10704_CR13","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1101\/cshperspect.a025320","volume":"195","author":"D Horn","year":"2014","unstructured":"Horn D (2014) Antigenic variation in African trypanosomes. Mol Biochem Parasitol 195(2):123\u2013129. https:\/\/doi.org\/10.1101\/cshperspect.a025320","journal-title":"Mol Biochem Parasitol"},{"issue":"4","key":"10704_CR14","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/nrmicro.2016.193","volume":"15","author":"MC Field","year":"2017","unstructured":"Field MC, Horn D, Fairlamb AH, Ferguson MA, Gray DW, Read KD, De Rycker M, Torrie LS, Wyatt PG, Wyllie S (2017) Anti-trypanosomatid drug discovery: an ongoing challenge and a continuing need. Nat Rev Microbiol 15(4):217\u2013231. https:\/\/doi.org\/10.1038\/nrmicro.2016.193","journal-title":"Nat Rev Microbiol"},{"issue":"15","key":"10704_CR15","doi-asserted-by":"publisher","first-page":"4629","DOI":"10.3390\/molecules26154629","volume":"26","author":"V Kourbeli","year":"2021","unstructured":"Kourbeli V, Chontzopoulou E, Moschovou K, Pavlos D, Mavromoustakos T, Papanastasiou IP (2021) An overview on target-based drug design against kinetoplastid protozoan infections: human African trypanosomiasis, chagas disease and leishmaniases. Molecules 26(15):4629. https:\/\/doi.org\/10.3390\/molecules26154629","journal-title":"Molecules"},{"issue":"2","key":"10704_CR16","doi-asserted-by":"publisher","first-page":"128","DOI":"10.3390\/ph15020128","volume":"15","author":"M Imran","year":"2022","unstructured":"Imran M, Khan SA, Alshammari MK, Alqahtani AM, Alanazi TA, Kamal M, Jawaid T, Ghoneim MM, Alshehri S, Shakeel F (2022) Discovery, development, inventions and patent review of fexinidazole: the first all-oral therapy for human African trypanosomiasis. Pharmaceuticals 15(2):128. https:\/\/doi.org\/10.3390\/ph15020128","journal-title":"Pharmaceuticals"},{"issue":"7","key":"10704_CR17","doi-asserted-by":"publisher","first-page":"2893","DOI":"10.1128\/AAC.00332-10","volume":"54","author":"AY Sokolova","year":"2010","unstructured":"Sokolova AY, Wyllie S, Patterson S, Oza SL, Read KD, Fairlamb AH (2010) Cross-resistance to nitro drugs and implications for treatment of human African trypanosomiasis. Antimicrob Agents Chemother 54(7):2893\u20132900. https:\/\/doi.org\/10.1128\/AAC.00332-10","journal-title":"Antimicrob Agents Chemother"},{"issue":"9173","key":"10704_CR18","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/S0140-6736(05)75299-5","volume":"354","author":"P Trouiller","year":"1999","unstructured":"Trouiller P, Olliaro PL (1999) Drug development output: what proportion for tropical diseases? Lancet 354(9173):164. https:\/\/doi.org\/10.1016\/S0140-6736(05)75299-5","journal-title":"Lancet"},{"issue":"9","key":"10704_CR19","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1038\/nrd1824","volume":"4","author":"R Pink","year":"2005","unstructured":"Pink R, Hudson A, Mouri\u00e8s MA, Bendig M (2005) Opportunities and challenges in antiparasitic drug discovery. Nat Rev Drug Discovery 4(9):727\u2013740. https:\/\/doi.org\/10.1038\/nrd1824","journal-title":"Nat Rev Drug Discovery"},{"key":"10704_CR20","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-62703-342-8_6","author":"R Guha","year":"2013","unstructured":"Guha R (2013) On exploring structure-activity relationships. In Silico Models Drug Discov. https:\/\/doi.org\/10.1007\/978-1-62703-342-8_6","journal-title":"In Silico Models Drug Discov"},{"issue":"5","key":"10704_CR21","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1046\/j.1365-3156.2001.00713.x","volume":"6","author":"J Keiser","year":"2001","unstructured":"Keiser J, Burri C (2001) Evaluation of quinolone derivatives for antitrypanosomal activity. Tropical Med Int Health 6(5):369\u2013389. https:\/\/doi.org\/10.1046\/j.1365-3156.2001.00713.x","journal-title":"Tropical Med Int Health"},{"issue":"9","key":"10704_CR22","first-page":"2741","volume":"61","author":"DE King","year":"2000","unstructured":"King DE, Malone R, Lilley SH (2000) New classification and update on the quinolone antibiotics. Am Fam Physician 61(9):2741\u20132748","journal-title":"Am Fam Physician"},{"issue":"4","key":"10704_CR23","doi-asserted-by":"publisher","first-page":"577","DOI":"10.3109\/14756360903373350","volume":"25","author":"PC Sharma","year":"2010","unstructured":"Sharma PC, Jain A, Jain S, Pahwa R, Yar MS (2010) Ciprofloxacin: review on developments in synthetic, analytical, and medicinal aspects. J Enzyme Inhib Med Chem 25(4):577\u2013589. https:\/\/doi.org\/10.3109\/14756360903373350","journal-title":"J Enzyme Inhib Med Chem"},{"issue":"4","key":"10704_CR24","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1007\/s10096-014-2296-3","volume":"34","author":"A Dalhoff","year":"2015","unstructured":"Dalhoff A (2015) Antiviral, antifungal, and antiparasitic activities of fluoroquinolones optimized for treatment of bacterial infections: a puzzling paradox or a logical consequence of their mode of action? Eur J Clin Microbiol Infect Dis 34(4):661\u2013668. https:\/\/doi.org\/10.1007\/s10096-014-2296-3","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10704_CR25","first-page":"141","volume":"16","author":"D Betbeder","year":"1988","unstructured":"Betbeder D, Hutchison D, Baltz T, Cros S (1988) Trypanocidal and antitumor activities of nalidixic and oxolinic acid derivatives. Med Sci Res 16:141\u2013142","journal-title":"Med Sci Res"},{"issue":"8","key":"10704_CR26","doi-asserted-by":"publisher","first-page":"4442","DOI":"10.1128\/AAC.01757-15","volume":"60","author":"G Hiltensperger","year":"2016","unstructured":"Hiltensperger G, Hecht N, Kaiser M, Rybak JC, Hoerst A, Dannenbauer N, M\u00fcller-Buschbaum K, Bruhn H, Esch H, Lehmann L (2016) Quinolone amides as antitrypanosomal lead compounds with in vivo activity. Antimicrob Agents Chemother 60(8):4442\u20134452. https:\/\/doi.org\/10.1128\/AAC.01757-15","journal-title":"Antimicrob Agents Chemother"},{"issue":"9","key":"10704_CR27","doi-asserted-by":"publisher","first-page":"3015","DOI":"10.1128\/AAC.47.9.3015-3017.2003","volume":"47","author":"E Nenortas","year":"2003","unstructured":"Nenortas E, Kulikowicz T, Burri C, Shapiro TA (2003) Antitrypanosomal activities of fluoroquinolones with pyrrolidinyl substitutions. Antimicrob Agents Chemother 47(9):3015\u20133017. https:\/\/doi.org\/10.1128\/AAC.47.9.3015-3017.2003","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"10704_CR28","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1128\/AAC.01025-09","volume":"54","author":"SC Tang","year":"2010","unstructured":"Tang SC, Shapiro TA (2010) Newly identified antibacterial compounds are topoisomerase poisons in African trypanosomes. Antimicrob Agents Chemother 54(2):620\u2013626. https:\/\/doi.org\/10.1128\/AAC.01025-09","journal-title":"Antimicrob Agents Chemother"},{"issue":"8","key":"10704_CR29","doi-asserted-by":"publisher","first-page":"2066","DOI":"10.1128\/AAC.43.8.2066","volume":"43","author":"E Nenortas","year":"1999","unstructured":"Nenortas E, Burri C, Shapiro TA (1999) Antitrypanosomal activity of fluoroquinolones. Antimicrob Agents Chemother 43(8):2066\u20132068. https:\/\/doi.org\/10.1128\/AAC.43.8.2066","journal-title":"Antimicrob Agents Chemother"},{"issue":"9","key":"10704_CR30","doi-asserted-by":"publisher","first-page":"a025320","DOI":"10.1101\/cshperspect.a025320","volume":"6","author":"DC Hooper","year":"2016","unstructured":"Hooper DC, Jacoby GA (2016) Topoisomerase inhibitors: fluoroquinolone mechanisms of action and resistance. Cold Spring Harb Perspect Med 6(9):a025320","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"3","key":"10704_CR31","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.ijpddr.2014.07.006","volume":"4","author":"R Bala\u00f1a-Fouce","year":"2014","unstructured":"Bala\u00f1a-Fouce R, \u00c1lvarez-Velilla R, Fern\u00e1ndez-Prada C, Garc\u00eda-Estrada C, Reguera RM (2014) Trypanosomatids topoisomerase re-visited: new structural findings and role in drug discovery. Int J Parasitol Drugs Drug Resist 4(3):326\u2013337. https:\/\/doi.org\/10.1016\/j.ijpddr.2014.07.006","journal-title":"Int J Parasitol Drugs Drug Resist"},{"issue":"suppl_1","key":"10704_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/jac\/dkg212","volume":"51","author":"MI Andersson","year":"2003","unstructured":"Andersson MI, MacGowan AP (2003) Development of the quinolones. J Antimicrob Chemother 51(suppl_1):1\u201311. https:\/\/doi.org\/10.1093\/jac\/dkg212","journal-title":"J Antimicrob Chemother"},{"issue":"3","key":"10704_CR33","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1016\/j.bmcl.2008.11.078","volume":"19","author":"X Ma","year":"2009","unstructured":"Ma X, Zhou W, Brun R (2009) Synthesis, in vitro antitrypanosomal and antibacterial activity of phenoxy, phenylthio or benzyloxy substituted quinolones. Bioorg Med Chem Lett 19(3):986\u2013989. https:\/\/doi.org\/10.1016\/j.bmcl.2008.11.078","journal-title":"Bioorg Med Chem Lett"},{"issue":"1","key":"10704_CR34","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.tvjl.2005.07.010","volume":"172","author":"M Martinez","year":"2006","unstructured":"Martinez M, McDermott P, Walker R (2006) Pharmacology of the fluoroquinolones: a perspective for the use in domestic animals. Vet J 172(1):10\u201328","journal-title":"Vet J"},{"key":"10704_CR35","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/B978-0-12-013321-5.50007-2","volume":"21","author":"DT Chu","year":"1991","unstructured":"Chu DT, Fernandes PB (1991) Recent developments in the field of quinolone antibacterial agents. Adv Drug Res 21:39\u2013144. https:\/\/doi.org\/10.1016\/B978-0-12-013321-5.50007-2","journal-title":"Adv Drug Res"},{"issue":"6","key":"10704_CR36","first-page":"587","volume":"66","author":"PC Sharma","year":"2009","unstructured":"Sharma PC, Jain A, Jain S (2009) Fluoroquinolone antibacterials: a review on chemistry, microbiology and therapeutic prospects. Acta Pol Pharm 66(6):587\u2013604","journal-title":"Acta Pol Pharm"},{"issue":"2","key":"10704_CR37","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1111\/cbdd.13534","volume":"94","author":"P Cilliers","year":"2019","unstructured":"Cilliers P, Seldon R, Smit FJ, Aucamp J, Jordaan A, Warner DF, N\u2019Da DD (2019) Design, synthesis, and antimycobacterial activity of novel ciprofloxacin derivatives. Chem Biol Drug Des 94(2):1518\u20131536. https:\/\/doi.org\/10.1111\/cbdd.13534","journal-title":"Chem Biol Drug Des"},{"issue":"1","key":"10704_CR38","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.tvjl.2005.07.010","volume":"41","author":"B Meunier","year":"2008","unstructured":"Meunier B (2008) Hybrid molecules with a dual mode of action: dream or reality? Acc Chem Res 41(1):69\u201377. https:\/\/doi.org\/10.1016\/j.tvjl.2005.07.010","journal-title":"Acc Chem Res"},{"key":"10704_CR39","doi-asserted-by":"publisher","DOI":"10.5772\/intechopen.92692","author":"AA Ali","year":"2020","unstructured":"Ali AA (2020) 1, 2, 3-triazoles: synthesis and biological application. IntechOpen. https:\/\/doi.org\/10.5772\/intechopen.92692","journal-title":"IntechOpen"},{"issue":"1","key":"10704_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3109\/14756360903524304","volume":"26","author":"R Kharb","year":"2011","unstructured":"Kharb R, Sharma PC, Yar MS (2011) Pharmacological significance of triazole scaffold. J Enzyme Inhib Med Chem 26(1):1\u201321. https:\/\/doi.org\/10.3109\/14756360903524304","journal-title":"J Enzyme Inhib Med Chem"},{"issue":"4","key":"10704_CR41","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1007\/s00044-018-2146-4","volume":"27","author":"AH Tarawneh","year":"2018","unstructured":"Tarawneh AH, Al-Momani L, Le\u00f3n F, Jain SK, Gadetskaya AV, Abu-Orabi ST, Tekwani BL, Cutler SJ (2018) Evaluation of triazole and isoxazole derivatives as potential anti-infective agents. Med Chem Res 27(4):1269\u20131275. https:\/\/doi.org\/10.1007\/s00044-018-2146-4","journal-title":"Med Chem Res"},{"issue":"16","key":"10704_CR42","doi-asserted-by":"publisher","first-page":"2060","DOI":"10.2174\/156802611796575902","volume":"11","author":"GI Lepesheva","year":"2011","unstructured":"Lepesheva GI, Waterman MR (2011) Sterol 14alpha-demethylase (CYP51) as a therapeutic target for human trypanosomiasis and leishmaniasis. Curr Top Med Chem 11(16):2060\u20132071. https:\/\/doi.org\/10.2174\/156802611796575902","journal-title":"Curr Top Med Chem"},{"issue":"9","key":"10704_CR43","doi-asserted-by":"publisher","first-page":"3061","DOI":"10.1007\/s00436-020-06796-z","volume":"119","author":"GES Batiha","year":"2020","unstructured":"Batiha GES, Tayebwa DS, Beshbishy AM, N\u2019Da DD, Yokoyama N, Igarashi I (2020) Inhibitory effects of novel ciprofloxacin derivatives on the growth of four Babesia species and Theileria equi. Parasitol Res 119(9):3061\u20133073. https:\/\/doi.org\/10.1007\/s00436-020-06796-z","journal-title":"Parasitol Res"},{"key":"10704_CR44","doi-asserted-by":"publisher","DOI":"10.1292\/jvms.14-0273","author":"K Suganuma","year":"2014","unstructured":"Suganuma K, Allamanda P, Hakimi H, Zhou M, Angeles JM, Kawazu SI, Inoue N (2014) Establishment of ATP-based luciferase viability assay in 96-well plate for Trypanosoma congolense. J Vet Med Sci. https:\/\/doi.org\/10.1292\/jvms.14-0273","journal-title":"J Vet Med Sci"},{"issue":"2","key":"10704_CR45","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.ijpddr.2017.04.002","volume":"7","author":"K Suganuma","year":"2017","unstructured":"Suganuma K, Yamasaki S, Molefe NI, Musinguzi PS, Davaasuren B, Mossaad E, Narantsatsral S, Battur B, Battsetseg B, Inoue N (2017) The establishment of in vitro culture and drug screening systems for a newly isolated strain of Trypanosoma equiperdum. Int J Parasitol Drugs Drug Resist 7(2):200\u2013205. https:\/\/doi.org\/10.1016\/j.ijpddr.2017.04.002","journal-title":"Int J Parasitol Drugs Drug Resist"},{"issue":"11","key":"10704_CR46","doi-asserted-by":"publisher","first-page":"3372","DOI":"10.3390\/molecules26113372","volume":"26","author":"L Munsimbwe","year":"2021","unstructured":"Munsimbwe L, Seetsi A, Namangala B, N\u2019Da DD, Inoue N, Suganuma K (2021) In vitro and in vivo trypanocidal efficacy of synthesized nitrofurantoin analogs. Molecules 26(11):3372. https:\/\/doi.org\/10.3390\/molecules26113372","journal-title":"Molecules"},{"issue":"11","key":"10704_CR47","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1038\/nrd4683","volume":"14","author":"K Katsuno","year":"2015","unstructured":"Katsuno K, Burrows JN, Duncan K, Van Huijsduijnen RH, Kaneko T, Kita K, Mowbray CE, Schmatz D, Warner P, Slingsby B (2015) Hit and lead criteria in drug discovery for infectious diseases of the developing world. Nat Rev Drug Discov 14(11):751\u2013758. https:\/\/doi.org\/10.1038\/nrd4683","journal-title":"Nat Rev Drug Discov"},{"issue":"11","key":"10704_CR48","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1038\/nrd2144","volume":"5","author":"S Nwaka","year":"2006","unstructured":"Nwaka S, Hudson A (2006) Innovative lead discovery strategies for tropical diseases. Nat Rev Drug Discov 5(11):941\u2013955. https:\/\/doi.org\/10.1038\/nrd2144","journal-title":"Nat Rev Drug Discov"},{"issue":"9","key":"10704_CR49","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1177\/1934578X13008009","volume":"8","author":"EA Adewusi","year":"2013","unstructured":"Adewusi EA, Steenkamp P, Fouche G, Steenkamp V (2013) Isolation of cycloeucalenol from Boophone disticha and evaluation of its cytotoxicity. Nat Prod Commun 8(9):906. https:\/\/doi.org\/10.1177\/1934578X13008009","journal-title":"Nat Prod Commun"},{"issue":"20","key":"10704_CR50","doi-asserted-by":"publisher","first-page":"4632","DOI":"10.1021\/jf501351r","volume":"62","author":"J Fu","year":"2014","unstructured":"Fu J, Chen H, Soroka DN, Warin RF, Sang S (2014) Cysteine-conjugated metabolites of ginger components, shogaols, induce apoptosis through oxidative stress-mediated p53 pathway in human colon cancer cells. J Agric Food Chem 62(20):4632\u20134642. https:\/\/doi.org\/10.1021\/jf501351r","journal-title":"J Agric Food Chem"},{"issue":"10","key":"10704_CR51","doi-asserted-by":"publisher","first-page":"329","DOI":"10.3390\/md15100329","volume":"15","author":"S Liu","year":"2017","unstructured":"Liu S, Su M, Song SJ, Jung JH (2017) Marine-derived Penicillium species as producers of cytotoxic metabolites. Mar Drugs 15(10):329. https:\/\/doi.org\/10.3390\/md15100329","journal-title":"Mar Drugs"},{"issue":"2","key":"10704_CR52","doi-asserted-by":"publisher","first-page":"135","DOI":"10.7124\/bc.00094B","volume":"33","author":"N Finiuk","year":"2017","unstructured":"Finiuk N, Hreniuh V, Ostapiuk YV, Matiychuk V, Frolov D, Obushak M, Stoika R, Babsky A (2017) Antineoplastic activity of novel thiazole derivatives. Biopolym Cell 33(2):135\u2013146. https:\/\/doi.org\/10.7124\/bc.00094B","journal-title":"Biopolym Cell"},{"issue":"1","key":"10704_CR53","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1038\/nbt.2786","volume":"32","author":"M Hay","year":"2014","unstructured":"Hay M, Thomas DW, Craighead JL, Economides C, Rosenthal J (2014) Clinical development success rates for investigational drugs. Nat Biotechnol 32(1):40\u201351. https:\/\/doi.org\/10.1038\/nbt.2786","journal-title":"Nat Biotechnol"},{"issue":"1\u20133","key":"10704_CR54","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/S0169-409X(96)00423-1","volume":"23","author":"CA Lipinski","year":"1997","unstructured":"Lipinski CA, Lombardo F, Dominy BW, Feeney PJ (1997) Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev 23(1\u20133):3\u201325. https:\/\/doi.org\/10.1016\/S0169-409X(96)00423-1","journal-title":"Adv Drug Deliv Rev"},{"key":"10704_CR55","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1007\/978-3-030-84860-6_11","volume-title":"The ADME Encyclopedia: A Comprehensive Guide on Biopharmacy and Pharmacokinetics","author":"A Talevi","year":"2022","unstructured":"Talevi A (2022) The ADME Encyclopedia: A Comprehensive Guide on Biopharmacy and Pharmacokinetics. Springer, Cham, pp 725\u2013732. https:\/\/doi.org\/10.1007\/978-3-030-84860-6_11"},{"key":"10704_CR56","unstructured":"MSD Veterinary Manual. Quinolones, Including Fluoroquinolones, Use in Animals. https:\/\/www.msdvetmanual.com\/pharmacology\/antibacterial-agents\/quinolones,-including-fluoroquinolones,-use-in-animals. Accessed 20 Jun 2023"},{"issue":"6","key":"10704_CR57","doi-asserted-by":"publisher","first-page":"1943","DOI":"10.1021\/cr068410e","volume":"108","author":"MC Pacheco","year":"2008","unstructured":"Pacheco MC, Purser S, Gouverneur V (2008) The chemistry of propargylic and allylic fluorides. Chem Rev 108(6):1943\u20131981. https:\/\/doi.org\/10.1021\/cr068410e","journal-title":"Chem Rev"},{"issue":"2","key":"10704_CR58","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1039\/B610213C","volume":"37","author":"S Purser","year":"2008","unstructured":"Purser S, Moore PR, Swallow S, Gouverneur V (2008) Fluorine in medicinal chemistry. Chem Soc Rev 37(2):320\u2013330. https:\/\/doi.org\/10.1039\/B610213C","journal-title":"Chem Soc Rev"},{"issue":"3","key":"10704_CR59","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1002\/cbdv.200790032","volume":"4","author":"B Testa","year":"2007","unstructured":"Testa B, Kr\u00e4mer SD (2007) The biochemistry of drug metabolism: an introduction: part 2: redox reactions and their enzymes. Chem Biodivers 4(3):257\u2013405. https:\/\/doi.org\/10.1002\/cbdv.200790032","journal-title":"Chem Biodivers"},{"issue":"1\u20132","key":"10704_CR60","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1081\/DMR-120001387","volume":"34","author":"PF Hollenberg","year":"2002","unstructured":"Hollenberg PF (2002) Characteristics and common properties of inhibitors, inducers, and activators of CYP enzymes. Drug Metab Rev 34(1\u20132):17\u201335. https:\/\/doi.org\/10.1081\/DMR-120001387","journal-title":"Drug Metab Rev"},{"issue":"6","key":"10704_CR61","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1177\/0091270007312153","volume":"48","author":"SM Huang","year":"2008","unstructured":"Huang SM, Strong JM, Zhang L, Reynolds KS, Nallani S, Temple R, Abraham S, Habet SA, Baweja RK, Burckart GJ (2008) New era in drug interaction evaluation: US Food and Drug Administration update on CYP enzymes, transporters, and the guidance process. J Clin Pharmacol 48(6):662\u2013670. https:\/\/doi.org\/10.1177\/0091270007312153","journal-title":"J Clin Pharmacol"},{"key":"10704_CR62","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/B978-0-444-53490-3.00011-X","volume":"114","author":"V Lejon","year":"2013","unstructured":"Lejon V, Bentivoglio M, Franco JR (2013) Human African trypanosomiasis. Handb Clin Neurol 114:169\u2013181. https:\/\/doi.org\/10.1016\/B978-0-444-53490-3.00011-X","journal-title":"Handb Clin Neurol"},{"issue":"1","key":"10704_CR63","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1074\/jbc.M207215200","volume":"278","author":"HP Green","year":"2003","unstructured":"Green HP, Portela MD, Jean EN, Lugli EB, Raper J (2003) Evidence for a Trypanosoma brucei lipoprotein scavenger receptor. J Biol Chem 278(1):422\u2013427. https:\/\/doi.org\/10.1074\/jbc.M207215200","journal-title":"J Biol Chem"},{"issue":"1","key":"10704_CR64","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1002\/aoc.368","volume":"17","author":"AJ Nok","year":"2003","unstructured":"Nok AJ, Nock IH, Bonire JJ (2003) The cholesterol pathway of Trypanosoma congolense could be a target for triphenyltinsalicylate and triphenylsiliconsalicylate inhibition. Appl Organomet Chem 17(1):17\u201322. https:\/\/doi.org\/10.1002\/aoc.368","journal-title":"Appl Organomet Chem"},{"issue":"1","key":"10704_CR65","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1039\/C8MD00425K","volume":"10","author":"A Rahman","year":"2019","unstructured":"Rahman A, O\u2019Sullivan P, Rozas I (2019) Recent developments in compounds acting in the DNA minor groove. Medchemcomm 10(1):26\u201340. https:\/\/doi.org\/10.1039\/C8MD00425K","journal-title":"Medchemcomm"},{"key":"10704_CR66","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2020.112558","author":"C Fersing","year":"2020","unstructured":"Fersing C, Boudot C, Castera-Ducros C, Pinault \u00c9, Hutter S, Paoli-Lombardo R, Primas N, Pedron J, S\u00e9guy L, Bourgeade-Delmas S, Sournia-Saquet A, Stigliani J, Brossas J, Paris L, Valentin A, Wyllie S, Fairlamb AH, Boutet-Robinet E, Corvaisier S, Since M, Malzert-Fr\u00e9on A, Destere A, Mazier D, Rathelot P, Courtioux B, Azas N, Verhaeghe P, Vanelle P (2020) 8-Alkynyl-3-nitroimidazopyridines display potent antitrypanosomal activity against both T. b. brucei and cruzi. Eur J Med Chem. https:\/\/doi.org\/10.1016\/j.ejmech.2020.112558","journal-title":"Eur J Med Chem"},{"issue":"1","key":"10704_CR67","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/srep42717","volume":"7","author":"A Daina","year":"2017","unstructured":"Daina A, Michielin O, Zoete V (2017) SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci Rep 7(1):1\u201313. https:\/\/doi.org\/10.1038\/srep42717","journal-title":"Sci Rep"},{"issue":"2","key":"10704_CR68","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1017\/S0031182000062533","volume":"102","author":"H Hirumi","year":"1991","unstructured":"Hirumi H, Hirumi K (1991) In vitro cultivation of Trypanosoma congolense bloodstream forms in the absence of feeder cell layers. Parasitology 102(2):225\u2013236. https:\/\/doi.org\/10.1017\/S0031182000062533","journal-title":"Parasitology"}],"container-title":["Molecular Diversity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-023-10704-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11030-023-10704-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-023-10704-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,4]],"date-time":"2024-10-04T04:08:02Z","timestamp":1728014882000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11030-023-10704-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,23]]},"references-count":68,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["10704"],"URL":"https:\/\/doi.org\/10.1007\/s11030-023-10704-9","relation":{},"ISSN":["1381-1991","1573-501X"],"issn-type":[{"value":"1381-1991","type":"print"},{"value":"1573-501X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,23]]},"assertion":[{"value":"14 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest. The funders had no role in the design of the study, in the collection, analyses, or interpretation of the data, in the writing of the manuscript, nor in the decision to publish the results.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable<b>.<\/b> MDBK was purchased from JCRB cell bank, National Institute of Biomedical Innovation, Health and Nutrition. <i>T. b. brucei<\/i> GUTat3.1, <i>T. b. gambiense<\/i> IL1922, <i>T. b. rhodesiense<\/i> IL1501, <i>T. congolense<\/i> IL3000, and <i>T. evansi<\/i> Tansui were provided by Dr. Hirumi. <i>T. equiperdum<\/i> IVM-t1 was established by Dr. Suganuma.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}